Junshi bio major shareholders' stake falls below 5%

Shanghai Junshi Biosciences Co., Ltd. announced on December 3, 2025, that its major shareholders, Greenland Finance, Shanghai Jiacai, and Greenland, have seen their combined equity proportion decrease from 5.0051% to 4.7129% of the company's total shares. This change, attributed to Greenland's H share lending for business needs, triggered the 5% threshold disclosure requirement.

The total number of shares held by these parties decreased from 51,386,400 to 48,386,400. Specifically, Greenland's direct shareholding decreased from 25,072,200 shares (2.4420%) to 22,072,200 shares (2.1498%). This equity change did not involve a tender offer, nor did it alter the company's controlling shareholders or actual controllers.

The announcement further clarified that the information regarding this equity change, including the "Simplified Change in Equity Report," will be disclosed by the information disclosure obligors on the Shanghai Stock Exchange website. The company's board of directors, including chairman Xiong Jun, confirmed the factual accuracy of the announcement.